Sol-Gel Technologies (SLGL) Long-Term Investments (2016 - 2026)
Sol-Gel Technologies (SLGL) posted quarterly Long-Term Investments of $1.3 million for Q1 2026, up 2.71% year-over-year from $1.3 million in Q1 2025, and little changed quarter-over-quarter from $1.3 million in Q4 2025.
Analysis
Sol-Gel Technologies (SLGL) Long-Term Investments (2016 - 2026) Analysis & Trends
Sol-Gel Technologies (SLGL) has reported Long-Term Investments for 11 consecutive years, with $1.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Long-Term Investments rose 2.71% year-over-year to $1.3 million; the TTM figure through Mar 2026 stood at $1.3 million (up 2.71% YoY), while the FY2025 annual figure was $1.3 million, up 2.56% from the prior year.
- Long-Term Investments was little changed at $1.3 million in Q1 2026 per SLGL's latest filing, from $1.3 million in the prior quarter.
- Across five years, Long-Term Investments topped out at $1.3 million in Q1 2026 and bottomed at $1.3 million in Q1 2024.
- Historically, Long-Term Investments has averaged $1.3 million across 5 years, with a median of $1.3 million in 2024.
- Annual changes were most pronounced in 2024 — Long-Term Investments slipped 2.47% — and 2025, when it climbed 2.75%.
- Sol-Gel Technologies' Long-Term Investments stood at $1.3 million in 2022, then decreased by 0.31% to $1.3 million in 2023, then gained by 0.55% to $1.3 million in 2024, then climbed by 2.56% to $1.3 million in 2025, then grew by 0.3% to $1.3 million in 2026.
- Business Quant data shows SLGL's Long-Term Investments at $1.3 million in Q1 2026, $1.3 million in Q4 2025, and $1.3 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 5.79 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 9.83 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -4.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 1.77 Bn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 22.17 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 372.10 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Sol-Gel Technologies | 194.01 Mn | 146.08 Mn | - | 1.34 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.34 Mn |
| Mar 31, 2026 | 1.33 Mn |
| Dec 31, 2025 | 1.32 Mn |
| Sep 30, 2025 | 1.31 Mn |
| Jun 30, 2025 | 1.31 Mn |
| Mar 31, 2025 | 1.29 Mn |
| Dec 31, 2024 | 1.29 Mn |
| Sep 30, 2024 | 1.29 Mn |
| Jun 30, 2024 | 1.27 Mn |
| Mar 31, 2024 | 1.26 Mn |
| Dec 31, 2023 | 1.28 Mn |
| Sep 30, 2023 | 1.29 Mn |
| Jun 30, 2023 | 1.29 Mn |
| Mar 31, 2023 | 1.30 Mn |
| Dec 31, 2022 | 1.29 Mn |
| Sep 30, 2022 | 1.29 Mn |
| Jun 30, 2022 | 1.29 Mn |
| Mar 31, 2022 | 1.30 Mn |
| Dec 31, 2021 | 1.30 Mn |
| Sep 30, 2021 | 1.29 Mn |